Charles River collaborates with Lilly TuneLab platform

Charles River Laboratories has entered a collaboration with Eli Lilly and Company’s AI/ML-focused drug discovery platform, Lilly TuneLab. By incorporating nonclinical testing services, the partnership seeks to standardise testing protocols across organisations. Charles River provides research services and products to pharmaceutical, biotechnology, government, and academic clients worldwide. Credit: Gorodenkoff / Shutterstock.com. Charles River Laboratories International has entered a collaboration with Eli Lilly and Company’s artificial intelligence / machine learning (AI/ML)-focused drug discovery platform, Lilly TuneLab. Under the agreement, Charles River will offer nonclinical testing services to companies working with the TuneLab ecosystem. Combine business intelligence and editorial excellence to reach…

Source: Medical Device Network